FOLD Description — Amicus Therapeutics Inc

Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering medicines for diseases. Co.'s gene therapy portfolio pipeline include Pompe disease, Fabry disease, CDKL5 deficiency disorder, ceroid lipofuscinosis, neuronal, Mucopolysaccharidosis Type IIIB, as well as a program in Mucopolysaccharidosis Type IIIA. Co.'s collaboration with University of Pennsylvania also provides Co. with disease-specific access and option rights to develop new gene therapy platform technologies and programs for most lysosomal disorders and a portfolio of other rare diseases.

Company Name: 
Amicus Therapeutics Inc
Number of ETFs Holding FOLD: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   FOLD Weight   FOLD Amount 
 VTI   0.01%   $94,342,523         
 VB   0.07%   $80,107,505         
 IWM   0.14%   $68,319,228         
 XBI   0.96%   $62,840,804         
 VBK   0.17%   $46,238,840         
 VXF   0.05%   $37,236,281         
 IWO   0.26%   $23,514,206         
 VTWO   0.13%   $8,181,938         
 VHT   0.04%   $8,044,838         
 PBE   2.45%   $5,980,614         
List of all 35 ETFs holding FOLD »
Quotes delayed 20 minutes

Email EnvelopeFree FOLD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.56 out of 4)
60th percentile
(ranked higher than approx. 60% of all stocks covered)

Analysts Forecast:
FOLD Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding FOLD | Amicus Therapeutics Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.